Clinical Trial

Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to generate a prospective database of all patients evaluated for diffuse parenchymal lung diseases to provide much needed data on the various disease aetiologies, incidence and prevalence rates, clinical and radiological presentations, pathologic correlations, disease progression and response to treatment, and final outcomes in this group of patients in Singapore.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2012-05-16; most recent amendment 2024-04-18.
Trial Details
NCT Number NCT01600378
Lead Sponsor Singapore General Hospital
Conditions Diffuse Parenchymal Lung Diseases
Enrollment 500 participants
Start Date 2012-05
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2024-04-19